Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link

Opportunity	Posted	Closing
Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations Agency: NCCDPHP	04/16/18	06/18/18
State Physical Activity and Nutrition Program Agency: NCCDPHP	04/13/18	06/14/18
Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders Agency: NCBDDD	04/13/18	06/13/18
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	04/11/18	06/30/18
DoD Ovarian Cancer Clinical Development Award Agency: AMRAA	04/11/18	08/08/18
DoD Ovarian Cancer, Ovarian Cancer Academy- Early-Career Investigator Award Agency: AMRAA	04/11/18	08/08/18
DoD Ovarian Cancer, Omics Consortium Development Award Agency: AMRAA	04/11/18	08/08/18
DoD Ovarian Cancer Pilot Award Agency: AMRAA	04/11/18	08/22/18
DoD Ovarian Cancer Investigator-Initiated Research Award Agency: AMRAA	04/11/18	08/22/18
Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	04/10/18	07/01/18
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINIANIAIDNIAMSNICHDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNIMHD	04/03/18	08/31/18
Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/03/18	10/30/18
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNHLBINIAAANIDCRNINDS	03/30/18	09/07/19
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINCCIHODS	03/29/18	09/27/19
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/29/18	11/19/20
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNIMHNCINICHDOBSSR	03/29/18	08/01/18
Provision of Technical Assistance and Training Activities to Assure Comprehensive Cancer Control Outcomes Agency: NCCDPHP	03/29/18	05/30/18
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD	03/28/18	05/07/21
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH	03/28/18	05/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINICHDODS	03/27/18	05/07/21
DoD Breast Cancer, Breakthrough Award Levels 1 and 2 Agency: AMRAA	03/27/18	05/30/18
DoD Breast Cancer, Breakthrough Fellowship Award Agency: AMRAA	03/27/18	05/30/18
DoD Breast Cancer, Era of Hope Scholar Award Agency: AMRAA	03/27/18	05/30/18
DoD Breast Cancer, Innovator Award Agency: AMRAA	03/27/18	08/14/18
DoD Breast Cancer, Breakthrough Award Levels 3 and 4 Agency: AMRAA	03/27/18	08/14/18
DoD Breast Cancer, Distinguished Investigator Award Agency: AMRAA	03/27/18	08/14/18
Fiscal Year (FY) 2019 Department of Defense Multidisciplinary Research Program of the University Research Initiative (MURI) - ARMY SUBMISSION Agency: AMC	03/27/18	10/16/18
Assuring Radiation Protection (U18) Agency: FDA Institutions: CDRH	03/23/18	06/04/18
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIAAANIDANIMH	03/21/18	08/23/18
Implementing Alcohol Screening and Brief Intervention in Healthcare Systems Providing Women's Health Services Agency: NCBDDD	03/16/18	05/16/18
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) Agency: NIH Institutions: NCINHGRINIANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIMHNINRNIMHDNCCIHODPOARORWH	03/15/18	05/07/18
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/09/18	10/30/18
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/09/18	10/30/18
Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIEHS	03/06/18	07/11/18
Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIEHS	03/06/18	07/11/18
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIAAANIDCRNIDANINR	03/06/18	04/05/21
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required) Agency: NIH Institutions: OppNetNCINIANIDCDNCCIHOBSSR	03/02/18	04/13/19
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/27/18	10/11/19
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
Smart and Connected Health Agency: NSF	02/21/18	05/22/18
Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHORIP	02/20/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Agency: NIH Institutions: NCINIANIAAANIAMSNIDCRNIDANIEHSNIGMSNINR	02/20/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNCCIHORIP	02/16/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIDDKNIEHSNIMHNINDSNINRNIMHDNCCIH	02/16/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDANIDDKNIEHSNIGMSNIMHNINRNIMHDNCCIH	02/16/18	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNLMNIMHNINDSNINRNIMHDNCCIHORIP	02/15/18	01/07/21
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/14/18	08/15/18
Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNIAID	02/14/18	12/06/18
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
Cyber-Physical Systems Agency: NSF	02/10/18	05/09/18
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP	02/09/18	01/07/21
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) Agency: NIH Institutions: NIANCI	02/08/18	09/07/19
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: NIANCI	02/08/18	09/07/19
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	02/07/18	09/26/19
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	02/07/18	09/26/19
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCI	02/07/18	06/13/19
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional) Agency: NIH Institutions: NCI	02/07/18	06/13/19
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/18	05/07/21
Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/01/18	07/05/19
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	01/31/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	01/31/18	06/27/20
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/30/18	04/11/19
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/30/18	04/11/19
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/26/18	01/25/21
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) Agency: NIH Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP	01/25/18	09/07/21
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP	01/24/18	09/07/21
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	01/16/18	04/05/19
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH	01/16/18	04/05/19
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH	01/16/18	04/05/19
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	01/16/18	04/05/19
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
Limited Competition: Clinical Research Sites for MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01-Clinical Trials Not Allowed) Agency: NIH Institutions: NHLBINCINHGRINIANIAIDNICHDNIDCRNIDANIMHNINDSNINRNIMHD	12/22/17	05/02/18
Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01 Clinical Trials Not Allowed) Agency: NIH Institutions: NHLBINCINHGRINIANIAIDNICHDNIDANIDCRNIMHNINDSNINRNIMHD	12/22/17	05/02/18
Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIASWCRF	12/22/17	06/08/18
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIANCINEINICHDNIDCDNIDANINDSNCCIHOBSSR	12/21/17	01/07/19
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIBIB	12/21/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) Agency: NIH Institutions: NIANINRNIMHDNCI	12/15/17	05/07/20
Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIANCCIHNINRNIMHDNCINHLBI	12/15/17	05/07/20
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINCCIH	12/15/17	09/07/20
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNIMHDNINDSNINRNLMNCCIHORIPICs	12/13/17	01/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/06/17	03/12/21
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Agency: NIH Institutions: NCI	12/06/17	03/12/21
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs	12/06/17	01/07/21
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01, Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIANCCIHNINDSNIAAANICHD	12/06/17	09/07/18
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Research Experiences (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional) Agency: NIH Institutions: NCI	12/04/17	09/28/18
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/30/17	06/15/18
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIBIBNIDCDNIMHOBSSRNICHD	11/30/17	08/31/18
Image-guided Drug Delivery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	11/30/17	11/22/18
Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAMSORWH	11/30/17	06/07/19
Surgical Disparities Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAMSORWHNINRNICHD	11/30/17	06/07/19
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/30/17	11/13/20
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/30/17	06/13/19
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/30/17	06/13/19
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/29/17	01/09/20
Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/29/17	01/09/20
NIH Pathway to Independence Award (Parent K99/R00 - Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNINRNIMHDNCCIHNIEHS	11/29/17	01/07/21
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNLMNCCIHNINDSORIP	11/29/17	01/07/21
Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIDA	11/28/17	01/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIDA	11/28/17	01/07/20
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/28/17	04/11/19
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/28/17	04/11/19
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/28/17	04/11/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R01) - Clinical Trial Optional Agency: NIH Institutions: NCINIDCDNIDAOBSSR	11/22/17	05/07/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R21) - Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINIDCDNIDA	11/22/17	05/07/19
Education and Health: New Frontiers (R03) - Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIANICHDNIDA	11/22/17	01/07/19
Education and Health: New Frontiers (R01)- Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIANICHDNIDA	11/22/17	01/07/19
Education and Health: New Frontiers (R21)- Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIANICHDNIDA	11/22/17	01/07/19
Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNINR	11/21/17	03/29/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed Agency: NIH Institutions: OBSSRNCINIDCRNIDCD	11/21/17	05/07/19
Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Clinical Trials Not Allowed Agency: NIH Institutions: NCINIDCRNIDCDOBSSR	11/21/17	05/07/19
NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/21/17	01/07/20
Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWHOBSSR	11/21/17	09/07/19
Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWH	11/21/17	09/07/19
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIMHDNCCIHNIEHS	11/21/17	01/07/21
Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNIMHDNCCIHNINDS	11/21/17	01/07/21
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Agency: NIH Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA	11/21/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) Agency: NIH Institutions: NCI	11/20/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI	11/20/17	01/07/21
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/20/17	09/28/18
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/17/17	03/22/19
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAANCI	11/17/17	09/07/19
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/17/17	09/07/19
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/17/17	09/07/19
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/15/17	05/07/19
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Agency: NIH Institutions: NCI	11/15/17	01/09/20
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSODP	11/15/17	05/07/20
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINICHDNIDANIAMS	11/13/17	01/07/19
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/17	07/16/19
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/17	07/05/19
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	11/07/17	01/07/20
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	11/07/17	01/07/20
Bioengineering Research Partnerships (U01 Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINEINIAAANICHDNIDANIEHSNINDS	11/07/17	01/07/19
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials) Agency: NIH Institutions: OppNetNCINIDCRNIDCDNIANIDANIMHDNCCIHOBSSR	11/07/17	03/06/19
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNIANIAMSNIDDKNIDANIDCRNINDSNCCIHNIMHD	11/07/17	05/07/19
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINEINHGRINIAIDNIAMSNICHDNIDANIEHSNINDS	11/07/17	05/07/19
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCININRNIANIAMSNIDANIDCRNINDSNCCIHNIMHD	11/07/17	05/07/19
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHD	11/06/17	05/07/19
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINICHDORWH	11/06/17	01/07/19
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINICHDORWH	11/06/17	01/07/19
The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAAANIAIDNIDCDNIDCRNIDANIMHNIMHDOBSSR	11/06/17	09/07/18
The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAIDNIDANIDCDNIDCRNIMHNIMHDOBSSR	11/06/17	09/07/18
The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAIDNIDANIDCRNIMHNIMHDOBSSR	11/06/17	09/07/18
The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINIAIDNIDANIDCDNIDCRNIMHNIMHD	11/06/17	09/07/18
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	11/06/17	02/14/20
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIA	11/03/17	01/07/20
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	01/07/20
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIA	11/03/17	01/07/20
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	01/07/20
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	09/07/18
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	09/07/18
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSR	11/03/17	05/07/19
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNCCIHODPOBSSRNIMHD	11/03/17	05/07/19
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINIAAANCCIHODSNHLBI	11/02/17	05/07/19
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINHLBINIAAANICHDNINRODS	11/02/17	09/07/18
Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/02/17	01/07/19
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional Agency: NIH Institutions: OBSSRNCINIBIBNIDCD	11/02/17	01/07/19
Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/02/17	01/07/19
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBI	11/02/17	01/07/19
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBI	11/02/17	01/07/19
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH	11/02/17	02/29/20
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCI	11/01/17	05/07/20
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINCCIHODS	11/01/17	09/07/19
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	11/01/17	01/07/20
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	11/01/17	01/07/20
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIDDK	11/01/17	11/05/19
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/01/17	05/07/19
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINICHDNIDANCCIHODS	11/01/17	05/07/18
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCI	10/31/17	01/07/21
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) Agency: NIH Institutions: NCI	10/31/17	01/07/21
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/30/17	01/07/20
Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCINHLBINIANIDCDNIDANIMHNLMODPOBSSRNIAAA	10/20/17	06/07/19
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH	10/17/17	01/07/21
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) Agency: NIH Institutions: NCINIDCR	10/12/17	01/07/21
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed Agency: NIH Institutions: NCI	10/12/17	10/08/20
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	10/12/17	10/08/20
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDANCCIH	10/10/17	01/07/21
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/03/17	01/07/21
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/29/17	01/07/21
Research to Improve Native American Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR	09/29/17	05/14/20
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR	09/29/17	05/14/20
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18) Agency: NIH Institutions: OppNetNCINIDCRNIDCDNIDANIMHDNCCIHOBSSRNIA	09/19/17	03/06/19
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	09/13/17	12/04/19
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	09/13/17	12/04/19
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	09/07/17	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	09/07/17	06/27/20
Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01) Agency: NIH Institutions: NIMHDNCINHLBINIANINR	08/25/17	11/15/19
Stimulating Access to Research in Residency (StARR) (R38) Agency: NIH Institutions: NHLBINCINIAID	08/23/17	01/24/20
Biology of Lung, and Head and Neck Preneoplasias (R21) Agency: NIH Institutions: NCI	08/16/17	01/07/21
Biology of Lung, and Head and Neck Preneoplasias (R01) Agency: NIH Institutions: NCI	08/15/17	01/07/21
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) Agency: NIH Institutions: NCI	08/04/17	09/07/20
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) Agency: NIH Institutions: NCI	08/04/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) Agency: NIH Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD	08/01/17	09/07/20
Assay development and screening for discovery of chemical probes or therapeutic agents (R01) Agency: NIH Institutions: NCINIAIDNIDCDNIDANIMH	07/27/17	09/07/20
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
2017 Human Exploration Research Opportunities (HERO) Agency: JSC	07/06/17	09/07/18
Multidisciplinary Studies of HIV/AIDS and Aging (R21) Agency: NIH Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01) Agency: NIH Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R21) Agency: NIH Institutions: NCI	06/22/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R01) Agency: NIH Institutions: NCI	06/22/17	09/07/20
HIV/AIDS and the Tumor Niche (R01) Agency: NIH Institutions: NCI	05/26/17	08/07/18
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) Agency: NIH Institutions: NCI	05/16/17	09/07/20
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21) Agency: NIH Institutions: NCI	05/16/17	09/07/20
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21) Agency: NIH Institutions: NIAIDNCINIAAA	05/12/17	05/07/20
Genomic Community Resources (U24) Agency: NIH Institutions: NHGRINCI	05/08/17	01/25/20
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Agency: NIH Institutions: NCI	04/04/17	05/07/20
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Agency: NIH Institutions: NCI	04/03/17	05/07/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Innovative Research in Cancer Nanotechnology (IRCN) (R01) Agency: NIH Institutions: NCI	03/30/17	05/21/20
Centers for AIDS Research (P30) Agency: NIH Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC	03/30/17	08/17/19
Developmental Centers for AIDS Research (P30) Agency: NIH Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC	03/30/17	08/17/19
Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) Agency: NIH Institutions: NIMHDNCINIANIAAANCCIHORWHNIDA	03/29/17	07/11/19
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01) Agency: NIH Institutions: NIMHDNCINHLBINIANIAAANINRNCCIHORWHNIDA	03/29/17	07/11/19
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Agency: NIH Institutions: NCI	03/29/17	05/07/20
Mechanisms of Alcohol-associated Cancers (R21) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Mechanisms of Alcohol-associated Cancers (R01) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) Agency: NIH Institutions: NCI	03/08/17	02/07/19
Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01) Agency: NIH Institutions: NCI	03/08/17	02/07/19
Inter-organelle Communication in Cancer (R21) Agency: NIH Institutions: NCI	03/07/17	01/15/20
Inter-organelle Communication in Cancer (R01) Agency: NIH Institutions: NCI	03/07/17	01/15/20
Energy for Sustainability Agency: NSF	02/22/17	10/22/18
Thermal Transport Processes Agency: NSF	02/22/17	10/22/18
Biophotonics Agency: NSF	02/22/17	10/22/18
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01) Agency: NIH Institutions: NCI	02/21/17	01/07/19
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21) Agency: NIH Institutions: NIMHDNCINIAAA	02/02/17	04/04/19
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) Agency: NIH Institutions: NIMHDNCINIAAA	02/02/17	04/04/19
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) Agency: NIH Institutions: NIMHNCINHGRINIAMSNIDCRNIDDKNIEHSNCCIHNCATS	02/01/17	01/05/20
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) Agency: NIH Institutions: NIMHNCINEINHGRINIAMSNIDCRNIDANIDDKNIEHSNIGMSNCCIHNCATS	02/01/17	01/05/20
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) Agency: NIH Institutions: NCI	12/21/16	01/07/20
Fertility Status as a Marker for Overall Health (R01) Agency: NIH Institutions: NICHDNIEHSODP	12/19/16	05/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R01) Agency: NIH Institutions: NCINIDA	12/15/16	01/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R21) Agency: NIH Institutions: NCINIDA	12/15/16	01/07/20
National Cancer Institute Youth Enjoy Science Research Education Program (R25) Agency: NIH Institutions: NCI	11/25/16	09/07/19
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01) Agency: NIH Institutions: NIMHDNCINIAAANIDCRNIDANIEHS	11/01/16	01/07/20
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) Agency: NIH Institutions: NIMHDNCINIAAANIDCRNIDANIEHS	11/01/16	01/07/20
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01) Agency: NIH Institutions: NCI	10/04/16	10/28/19
Emerging Global Leader Award (K43) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	10/04/16	12/14/18
Kidney Precision Medicine Project - Technology Development and Validation (R43/R44) Agency: NIH Institutions: NIDDK	09/28/16	01/05/20
Kidney Precision Medicine Project - Technology Development and Validation (R41/R42) Agency: NIH Institutions: NIDDK	09/28/16	01/05/20
Support of Competitive Research (SCORE) Pilot Project Award (SC2) Agency: NIH Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDS	09/21/16	09/07/19
Support of Competitive Research (SCORE) Research Advancement Award (SC1) Agency: NIH Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIEHS	09/21/16	09/07/19
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) Agency: NIH Institutions: NCINIDCR	09/07/16	09/07/19
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01) Agency: NIH Institutions: NCINIDCR	09/07/16	09/07/19
Secondary Analyses of Alcohol and Chronic Disease (R03) Agency: NIH Institutions: NIAAANCI	08/10/16	09/07/19
Secondary Analyses of Alcohol and Chronic Disease (R01) Agency: NIH Institutions: NIAAANCI	08/10/16	09/07/19
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) Agency: NIH Institutions: NCI	08/05/16	06/14/18
Social Epigenomics Research Focused on Minority Health and Health Disparities (R21) Agency: NIH Institutions: NIMHDNCINIA	07/07/16	11/15/18
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01) Agency: NIH Institutions: NIMHDNCINIA	07/07/16	11/15/18
New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3) Agency: NIH Institutions: NCI	06/29/16	04/16/19
Biological Comparisons in Patient-Derived Models of Cancer (U01) Agency: NIH Institutions: NCI	06/24/16	03/06/19
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03) Agency: NIH Institutions: NCI	06/16/16	07/16/19
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21) Agency: NIH Institutions: NCI	06/08/16	04/11/19
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01) Agency: NIH Institutions: NCI	06/08/16	04/11/19
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) Agency: NIH Institutions: NIDCRNIAORWH	05/27/16	09/07/19
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) Agency: NIH Institutions: NIDCRNIAORWH	05/27/16	09/07/19
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) Agency: NIH Institutions: NCI	05/23/16	06/13/19
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21) Agency: NIH Institutions: NCI	05/23/16	06/13/19
Serious Adverse Drug Reaction Research (R21) Agency: NIH Institutions: NHGRINCINIAIDNIAMSNINDS	05/19/16	09/07/19
Serious Adverse Drug Reaction Research (R01) Agency: NIH Institutions: NHGRINCINIAIDNIAMSNINDSNIMHD	05/19/16	09/07/19
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Agency: NIH Institutions: NCI	05/16/16	09/07/19
Cancer-related Behavioral Research through Integrating Existing Data (R21) Agency: NIH Institutions: NCI	05/11/16	06/14/19
Cancer-related Behavioral Research through Integrating Existing Data (R01) Agency: NIH Institutions: NCI	05/11/16	06/07/19
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21) Agency: NIH Institutions: NCI	05/11/16	04/11/19
Gene Fusions in Pediatric Sarcomas (R21) Agency: NIH Institutions: NCI	05/10/16	05/07/19
Dissemination and Implementation Research in Health (R03) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSR	05/10/16	05/07/19
Gene Fusions in Pediatric Sarcomas (R01) Agency: NIH Institutions: NCI	05/10/16	05/07/19
Neural Regulation of Cancer (R21) Agency: NIH Institutions: NCININDS	05/09/16	06/27/19
Neural Regulation of Cancer (R01) Agency: NIH Institutions: NCININDS	05/09/16	06/27/19
Metabolic Reprogramming to Improve Immunotherapy (R21) Agency: NIH Institutions: NCI	05/06/16	09/07/19
Metabolic Reprogramming to Improve Immunotherapy (R01) Agency: NIH Institutions: NCI	05/06/16	09/07/19
The Role of Mobile Genetic Elements in Cancer (R21) Agency: NIH Institutions: NCINIA	05/05/16	09/07/19
The Role of Mobile Genetic Elements in Cancer (R01) Agency: NIH Institutions: NCINIA	05/05/16	09/07/19
Tools for Cell Line Identification (R43/R44) Agency: NIH Institutions: NIGMSNCINIANIAIDNIBIBNIDCRNIDANINDSNCATSORIPORWHNHGRI	04/15/16	04/05/19
Exploratory Grants in Cancer Epidemiology and Genomics Research (R21) Agency: NIH Institutions: NCI	04/08/16	05/07/19
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) Agency: NIH Institutions: NCI	04/08/16	07/16/19
Integrating Biospecimen Science into Clinical Assay Development (U01) Agency: NIH Institutions: NCI	04/05/16	06/22/18
Obesity Policy Evaluation Research (R01) Agency: NIH Institutions: NIDDKNCINIANICHDODPOBSSR	04/04/16	05/07/19
Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	03/17/16	09/07/18
Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25) Agency: NIH Institutions: NCI	03/17/16	09/07/18
Vet-LIRN Cooperative Agreement Program to Develop and Validate Testing Methods for Food Irradiation Specific Markers in Animal Feeds and Treats (U18) Agency: FDA Institutions: CVM	03/16/16	05/01/18
Emerging Questions in Cancer Systems Biology (U01) Agency: NIH Institutions: NCI	03/11/16	11/23/18
Spermatogenic Stem Cell Culture Systems to Preserve and Restore Reproductive Capacity in Males (R01) Agency: NIH Institutions: NICHD	02/25/16	06/05/18
Imaging and Biomarkers for Early Cancer Detection (U01) Agency: NIH Institutions: NCI	01/25/16	12/11/18
Education and Health: New Frontiers (R01) Agency: NIH Institutions: NCINIANICHDNIDAOBSSR	01/12/16	01/07/19
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01) Agency: NIH Institutions: NCI	12/07/15	11/17/18
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21) Agency: NIH Institutions: NCINICHDNIDANINDSNIAMS	11/20/15	01/07/19
Time-Sensitive Obesity Policy and Program Evaluation (R01) Agency: NIH Institutions: NIDDKNCINICHDOBSSRNIAODP	09/17/15	09/13/18
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Advanced Development of Informatics Technologies for Cancer Research and Management (U24) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Sustained Support for Informatics Resources for Cancer Research and Management (U24) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) Agency: NIH Institutions: NCI	08/18/15	11/20/18
Translational Studies on Adducts for Cancer Risk Identification and Prevention (U01) Agency: NIH Institutions: NCI	07/24/15	07/11/18
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Agency: NIH Institutions: NCI	07/14/15	08/15/18
Harnessing Big Data to Halt HIV (R01) Agency: NIH Institutions: NIAIDNCINIDANIMH	06/05/15	05/07/18
Fundamental Research to Counter Weapons of Mass Destruction Agency: DTRA	03/20/15	09/30/19
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01) Agency: NIH Institutions: NIDCRNCINICHDNIDDKNIDANIGMSNIAMSNCCIHODS	03/09/15	05/07/18
Chemical Measurement and Imaging Agency: NSF	07/14/09	10/31/18

TOP